Soleno Therapeutics (SLNO) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 79.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.21% |
| Dec 31, 2025 | 114.79% |
| Sep 30, 2025 | 84.12% |
| Jun 30, 2025 | 11.21% |
| Mar 31, 2025 | -97.02% |
| Dec 31, 2024 | -170.51% |
| Sep 30, 2024 | -111.14% |
| Jun 30, 2024 | -25.76% |
| Mar 31, 2024 | -33.70% |
| Dec 31, 2023 | -58.22% |
| Sep 30, 2023 | -8.32% |
| Jun 30, 2023 | -4.70% |
| Mar 31, 2023 | -12.57% |
| Dec 31, 2022 | 27.88% |
| Sep 30, 2022 | -107.22% |
| Jun 30, 2022 | 12.41% |
| Mar 31, 2022 | 6.62% |
| Dec 31, 2021 | -133.63% |
| Sep 30, 2021 | -52.19% |
| Jun 30, 2021 | -15.90% |
| Mar 31, 2021 | -33.02% |
| Dec 31, 2020 | 28.47% |
| Sep 30, 2020 | -50.80% |
| Jun 30, 2020 | -34.19% |
| Mar 31, 2020 | -42.02% |
| Dec 31, 2019 | -117.49% |
| Sep 30, 2019 | 35.73% |
| Jun 30, 2019 | -41.76% |
| Mar 31, 2019 | -30.15% |
| Dec 31, 2018 | 27.90% |
| Sep 30, 2018 | 11.16% |
| Jun 30, 2018 | -79.18% |
| Mar 31, 2018 | 31.14% |
| Dec 31, 2017 | -2.58% |
| Sep 30, 2017 | -1.36% |
| Jun 30, 2017 | -3.05% |
| Mar 31, 2017 | -34.85% |
| Dec 31, 2016 | -13.42% |
| Sep 30, 2016 | -3.78% |